INSIGHTS ON CLINICAL TRIAL DESIGN
-
Everything You Need To Know About Mobile Visits And Community Sites
Discover how decentralized clinical trials (DCTs) and mobile visits contribute to more diverse, efficient, and patient-centric research, ultimately enhancing trial outcomes and data quality.
-
Solutions To The Challenges Of Oncology Trials
This significant Phase III trial, one of the largest global studies in head and neck cancer, faced considerable challenges including enrollment delays and an intricate study design.
-
Traditional, Hybrid Or Decentralized: What Actually Works?
Learn how traditional, decentralized, and community-based approaches address different study challenges and support more effective, patient-centered research.
-
The Patient Recruitment Shift: Navigating Disruption, Delivering Precision
Explore the four macro trends reshaping the recruitment space in 2025—each grounded in emerging data, technology, and behavior shifts.
-
Beyond The Database: Reaching Real Patients In Real Communities5/14/2025
There’s fatigue around “database-only” recruitment tactics. This presentation spotlights how patient-centric, local engagement are outperforming traditional pipelines.
-
Why Bioanalysis Needs To Break Free From Manual Bottlenecks9/2/2025
Bioanalysis remains one of the most persistent bottlenecks in drug development, with CROs displaying inefficiencies that are no longer operational nuisances but strategic liabilities.
-
Reusable RTSM Reduces Risk And Speeds Change3/9/2026
Minimize human error and accelerate timelines with a reusable software framework. Automation provides deeper testing coverage and faster mid-study updates for more resilient clinical operations.
-
Five Preventable Clinical Design Pitfalls And How To Avoid Them7/21/2026
While late-stage trial attrition is often attributed to inadequate safety or efficacy, the true failure may be insufficient upstream planning and/or misalignment between clinical and commercial goals.
-
Data Privacy And Trust In China's Clinical Trials2/4/2026
China’s evolving privacy laws are reshaping how global trials operate. Sponsors that prioritize transparency and participant confidence can meet compliance demands while building lasting trust.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Veristat harnesses knowledge, expertise, and scale to provide superior solutions and progressive approaches to mitigate risks and achieve meaningful outcomes for biopharmaceutical and medical technology companies, and their patients.
-
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
At DVCR, our Central Laboratory Services are built for multi-site studies, combining customizable kits, next-day results and real-time shipment monitoring to keep every site aligned and on schedule. Backed by dedicated client teams, a comprehensive Central Lab Manual and rapid-response testing, we deliver the flexibility and speed your studies require.
-
Second, only to Oncology, CNS, and Neurology clinical trials are incredibly complex and complicated to navigate.
-
CSS offers customized patient recruitment and retention solutions across the globe, ensuring successful enrollment for clinical trials across various therapeutic areas.